Voxelotor Neurocognitive Function Study

NCT05228834 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Data will not inform further development of Voxelotor

Conditions

Sickle Cell Disease

Interventions

DRUG: Voxelotor Only Product in Oral Dose Form
DRUG: Placebo

Sponsor

Pfizer